Our vision is to be a world-leading source of trusted, high quality evidence, on which clinical decisions can be reliably based
Our vision is to be a global source of high quality evidence, on which clinical decisions can be reliably based.
To achieve this vision we will:
- Generate and synthesise high-quality evidence that benefits patients and society.
- Improve the diagnosis, prevention, and treatment of common primary care conditions.
- Build innovative tools to increase the impact of healthcare data in the real world.
- Deliver timely, innovative, and relevant outputs that directly affect policy and affect practice.
- Develop tools and materials for the general public to better understand research evidence and healthcare findings.
- Build research capacity by supporting the next generation of research leaders.
For over 20 years, the Centre for Evidence Based Medicine has been dedicated to conducting research for the benefit of patients, providers, and society. Over 20 individuals work in the Centre, with diverse backgrounds, including clinicians, methodologists, statisticians, and research administrators. We also have a global network of international research collaborators, supporting the delivery of our vision, from Europe, Africa, Canada, the USA, New Zealand, Australia, Singapore, and India. What unites them is a collective endeavour to provide high-quality evidence, on which clinical decisions can be reliably based.
We are based in the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Our institution is ranked number one in the world university rankings and our department is ranked number one in the UK for the quality of its research.
We align our research with the principles outlined in the EBM Manifesto.
In our research we seek to:
- involve patients, health professionals, and policy makers in the prioritisation, design, implementation, and dissemination of our results;
- prioritise systematic reviews and synthesis of existing evidence;
- be relevant, replicable, and accessible to identified end users;
- question clinical and research practices that may introduce biases, including research methods, scientific reporting, and conflicts of interests;
- apply world-leading expertise in research that underpins regulations of medications and devices;
- produce high-quality research that supports patient-focused clinical guidelines;
- support quality improvement in existing research methods and introducing innovative methods;
- share expertise and support the next generation of EBM research leaders.
The outputs from CEBMR emerge from six clinical areas:
CEBMR Focuses On:
- Improving the quality, reliability, and accessibility of the evidence that underpins medications, devices, operations, and other therapeutic interventions
- Exposing and challenging healthcare claims and regulatory failings that prioritise commercial interests over the interests of the public
- Improving understanding, transparency, and reporting of harms from medicines and other therapeutic interventions
- Generating knowledge to reduce the global burden of noncommunicable diseases
- Improving and implementing the evidence base for lifestyle changes and physical activity in healthcare settings
- Protecting patients from the harms of multimorbidity
- Improving the evidence base that informs how we routinely diagnose and screen conditions in clinical care
- Identifying and assessing new diagnostic technologies
- Preventing the harms of too much medicine
Global Health Services
- Improving the delivery, evaluation, and outcomes of health services
- Working with commissioners, guideline developers, and policy makers to ensure that the delivery of healthcare is evidence based
- Supporting the delivery of evidence-based healthcare in low- and middle-income countries and in humanitarian needs
- Building evidence-based products and tools to help patients, providers, and academics communicate evidence better
- Supporting the improved communication of cardiovascular risks
- Exploring how evidence can be used by school children
- The EBM Data Lab identifies and implements ways in which data can be used to build working, useful products that change healthcare for the better
- Using existing data sets to answer challenging questions in real world settings
- Using available data and audit to address key issues in evidence-based healthcare
We use applied and translational research methods to generate new knowledge, in order to inform healthcare decision making. Furthermore, we use our skills and expertise to identify, develop, and appropriately apply existing and new research methods, to achieve our vision.
Examples of the research methods we use include:
- Systematic reviews and evidence synthesis
- Quantitative methods, including clinical trials, Diagnostic Test Accuracy, and Clinical audit
- Data mining
- Mixed methods, combining quantitative and qualitative methods
- Investigative epidemiology
- Data visualisation
- Data Coding
The Centre for Evidence Based Medicine currently receives no core funding.
Like most academic organisations, we fund the majority of our research from grants won through open competition.
We neither seek nor accept funding for our research from pharmaceutical companies or other private enterprises with relevant conflicts of interest.